{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:15:28Z","timestamp":1769181328643,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Heart Foundation"},{"name":"Australian National Health and Medical Research Council"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.clinthera.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T20:02:36Z","timestamp":1541188956000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Colchicine in Stable Coronary Artery Disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Aernoud T.L.","family":"Fiolet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan M.","family":"Nidorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arend","family":"Mosterd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan H.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.09.011_bib1","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.09.011_bib2","series-title":"Top 10 causes of death worldwide","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.clinthera.2018.09.011_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Abubakar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.09.011_bib4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamacardio.2016.1326","article-title":"Recent trends in cardiovascular mortality in the United States and public health goals","volume":"1","author":"Sidney","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrcardio.2015.82","article-title":"Contributions of risk factors and medical care to cardiovascular mortality trends","volume":"12","author":"Ezzati","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib6","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.09.011_bib7","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2018.09.011_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2018.09.011_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2013.03.015","article-title":"Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease","volume":"166","author":"Sedlak","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2018.09.011_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2018.09.011_bib11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2018.09.011_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib13","series-title":"Atherothrombosis and coronary artery disease (2)","first-page":"1676","article-title":"Pathogensis of atherothrombosis. Role of vulnerable, ruptured, and erodod plaques","author":"Falk","year":"2004"},{"key":"10.1016\/j.clinthera.2018.09.011_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/sca.4950280101","article-title":"Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events\u2014a novel insight into plaque rupture by scanning electron microscopy","volume":"28","author":"Abela","year":"2006","journal-title":"Scanning"},{"key":"10.1016\/j.clinthera.2018.09.011_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.amjcard.2008.12.019","article-title":"Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes","volume":"103","author":"Abela","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2018.09.011_bib17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMra1601611","article-title":"Crystallopathies","volume":"374","author":"Mulay","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2018.09.011_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2018.09.011_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2018.09.011_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imm.12556","article-title":"Complementing the inflammasome","volume":"147","author":"Triantafilou","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.clinthera.2018.09.011_bib22","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","article-title":"Inflammation and its resolution as determinants of acute coronary syndromes","volume":"114","author":"Libby","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2018.09.011_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2018.09.011_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.09.011_bib25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2018.09.011_bib26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2018.09.011_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-13-67","article-title":"Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia","volume":"13","author":"Huang","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clinthera.2018.09.011_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0021-9150(79)90202-8","article-title":"Effects of anticalcifying and anti-fibrotic drugs on pre-established atherosclerosis in the rabbit","volume":"33","author":"Hollander","year":"1979","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2018.09.011_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arcmed.2015.01.004","article-title":"Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis","volume":"46","author":"Kong","year":"2015","journal-title":"Arch Med Res"},{"key":"10.1016\/j.clinthera.2018.09.011_bib30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib31","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","article-title":"Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims","volume":"75","author":"Solomon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2018.09.011_bib32","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","article-title":"Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study","volume":"60","author":"Deftereos","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.clinthera.2018.09.011_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib36","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","article-title":"Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty","volume":"19","author":"O'Keefe","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.09.011_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0735-1097(91)90948-9","article-title":"Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions","volume":"17","author":"Muller","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib39","series-title":"Colchicine cardiovascular outcomes trial (COLCOT)","author":"ClinicalTrials.gov","year":"2015"},{"key":"10.1016\/j.clinthera.2018.09.011_bib40","series-title":"Imazio COACS colchicine for acute coronary syndromes","author":"ClinicalTrials.gov","year":"2013"},{"key":"10.1016\/j.clinthera.2018.09.011_bib41","series-title":"The LoDoCo2 Trial: low dose colchicine for secondary prevention of cardiovascular disease","author":"ANZCTR","year":"2014"},{"key":"10.1016\/j.clinthera.2018.09.011_bib42","series-title":"Colchicine and spironolactone in patients with STEMI\/SYNERGY stent Registry (CLEAR-SYNERGY) NCT03048825","author":"ClinicalTrials.gov","year":"2017"},{"key":"10.1016\/j.clinthera.2018.09.011_bib43","series-title":"Colchicine for prevention of vascular inflammation in non-cardio embolic stroke (CONVINCE)","author":"ClinicalTrials.gov","year":"2016"},{"key":"10.1016\/j.clinthera.2018.09.011_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011047","article-title":"Colchicine for prevention of cardiovascular events","volume":"3","author":"Hemkens","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2018.09.011_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-015-0068-3","article-title":"Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Verma","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.clinthera.2018.09.011_bib46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.clinthera.2018.09.011_bib47","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM197410312911803","article-title":"A\u00a0controlled trial of colchicine in preventing attacks of familial Mediterranean fever","volume":"291","author":"Zemer","year":"1974","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2018.09.011_bib48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780340806","article-title":"Long-term colchicine treatment in children with familial Mediterranean fever","volume":"34","author":"Zemer","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.09.011_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2015.49807","article-title":"Statin intolerance\u2014an attempt at a unified definition. Position paper from an International Lipid Expert Panel","volume":"11","author":"Banach","year":"2015","journal-title":"Arch Med Sci AMS"},{"key":"10.1016\/j.clinthera.2018.09.011_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejvs.2009.01.009","article-title":"The prevalence of intolerance for low-dose acetylsalicylacid in the secondary prevention of atherothrombosis","volume":"37","author":"Tournoij","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.clinthera.2018.09.011_bib51","series-title":"FDA medical review. Colchicine for the treatment of FMF","author":"Hull","year":"2008"},{"key":"10.1016\/j.clinthera.2018.09.011_bib52","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1592\/phco.24.17.1784.52334","article-title":"Colchicine myotoxicity: case reports and literature review","volume":"24","author":"Wilbur","year":"2004","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.clinthera.2018.09.011_bib53","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1345\/aph.1H064","article-title":"Rhabdomyolysis in a patient treated with colchicine and atorvastatin","volume":"40","author":"Tufan","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2018.09.011_bib54","first-page":"264","article-title":"Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout","volume":"18","author":"Wallace","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib55","first-page":"1013","article-title":"Colchicine clearance is impaired in alcoholic cirrhosis","volume":"14","author":"Leighton","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2018.09.011_bib56","first-page":"48","article-title":"Colchicine","volume":"28","author":"Ben Chetrit","year":"1998","journal-title":"1998 Update. Semin Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.09.011_bib57","first-page":"515","article-title":"Acute colchicine intoxication during clarithromycin administration in patients with chronic renal failure","volume":"19","author":"Akdag","year":"2006","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib58","first-page":"494","article-title":"Acute colchicine intoxication\u2014possible role of erythromycin administration","volume":"19","author":"Caraco","year":"1992","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2018.09.011_bib59","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/431592","article-title":"Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study","volume":"41","author":"Hung","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.09.011_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11886-018-1008-5","article-title":"Colchicine in pericardial disease: from the underlying biology and clinical benefits to the drug-drug interactions in cardiovascular medicine","volume":"20","author":"Schenone","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.clinthera.2018.09.011_bib61","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1016\/j.amjmed.2017.04.032","article-title":"Risk of colchicine-associated myopathy in gout: influence of concomitant use of statin; methodologic issues","volume":"130","author":"Ayubi","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2018.09.011_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4137\/CMT.S10561","article-title":"Clinically significant pharmacokinetic interaction between colchicine and ritonavir in healthy volunteers","volume":"5","author":"Wason","year":"2013","journal-title":"Clin Med Insights Therapeutics"},{"key":"10.1016\/j.clinthera.2018.09.011_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13256-016-1169-z","article-title":"Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report","volume":"11","author":"Frydrychowicz","year":"2017","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.clinthera.2018.09.011_bib64","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2018.09.011_bib65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mus.20135","article-title":"Cytoskeletal myotoxicity from simvastatin and colchicine","volume":"30","author":"Baker","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinthera.2018.09.011_bib66","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1345\/aph.1E593","article-title":"Acute myopathy in a patient with concomitant use of pravastatin and colchicine","volume":"39","author":"Alayli","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2018.09.011_bib67","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2018.09.011_bib68","first-page":"421","article-title":"Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine","volume":"16","author":"Minetti","year":"2003","journal-title":"J\u00a0Nephrol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818304624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818304624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:17Z","timestamp":1758963017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818304624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0149291818304624"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.09.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine in Stable Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}